Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Mineralys Therapeutics granted a new non-executive employee an inducement stock option award covering 14,880 shares and an inducement restricted stock unit award covering 11,160 shares on September 21, 2026. The awards were made under the company's 2025 Employment Inducement Incentive Award Plan and vest over four years, with a 25% cliff at the first anniversary for the options and 25% on each of the first four anniversaries for the RSUs, subject to continued service.
Key figures
- Cliff
- 25%
- Vesting period
- four years
- Inducement rsu shares
- 11160
- Inducement option shares
- 14880
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.